Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 10/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.53 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.53 |
| ▸ | IDO1 | P14902 | 2/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.49 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.49 |
| ▸ | BCHE | P06276 | 4/20 | 0.49 |
| ▸ | ACHE | P22303 | 4/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | THPO | P40225 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29957820 | 1.00 | ALDH1A1 (0.54) | ALDH1A1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL6177247 | 0.89 | ALDH1A1 (0.47) | ALDH1A1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL1957955 | 0.85 | HTR7 (0.46) | ALDH1A1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL27527691 | 0.84 | CHRM2 (0.50) | ALDH1A1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL2167807 | 0.83 | CXCL8 (0.42) | ALDH1A1CHRM2CHRM1CHRM3HTT | |
| SCHEMBL7831223 | 0.83 | IDO1 (0.55) | ALDH1A1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL5205282 | 0.82 | CA12 (0.49) | ALDH1A1L3MBTL1KDM4ECYP3A4CYP2D6 | |
| SCHEMBL4949334 | 0.81 | KDM4E (0.43) | ALDH1A1CHRM2CHRM1CHRM3HTT | |
| SCHEMBL30753811 | 0.81 | TAAR1 (0.50) | ALDH1A1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL587268 | 0.81 | ATP4A (0.48) | ALDH1A1CHRM2CHRM1CHRM3IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2125736-A1 | SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS | Leo Pharma A/S (DK) | 2009-12-02 | — | — | EP | claimed |
| WO-2008077404-A1 | SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS | LEO PHARMA A/S (DK) | 2008-07-03 | — | — | WO | claimed |
| EP-1896492-A2 | PLATINUM COMPLEXES WITH MONONITRILE-CONTAINING LIGANDS | BIONUMERIK PHARMACEUTICALS, INC. (US) | 2008-03-12 | — | — | EP | claimed |
| US-20070173485-A1 | Amminecyclohexanecarbonitriledichloroplatinum; platinum is capable of rapidly undergoing chelation with the Guanine or Adenine base of a DNA oligonucleotide at the 7 position; readily taken up by tumor cells | JUNIPER NETWORKS, INC. | 2007-07-26 | — | — | US | claimed |
| US-7238823-B2 | Platinum complexes with mononitrile-containing ligands | BIONUMERIK PHARMACEUTICALS, INC. (US) | 2007-07-03 | — | — | US | claimed |
| WO-2007005056-A2 | PLATINUM COMPLEXES WITH MONONITRILE-CONTAINING LIGANDS | BIONUMERIK PHARMACEUTICALS, INC. (US) | 2007-01-11 | — | — | WO | claimed |
| US-20070004798-A1 | Platinum complexes with mononitrile-containing ligands | BIONUMERIK PHARMACEUTICALS, INC. | 2007-01-04 | — | — | US | claimed |
| EP-4704846-A2 | NOVEL ERGOLINES AND METHODS OF TREATING MOOD DISORDERS | Gilgamesh Pharmaceuticals, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4608829-A2 | NOVEL ERGOLINES AND METHODS OF TREATING MOOD DISORDERS | Gilgamesh Pharmaceuticals, Inc. (US) | 2025-09-03 | — | — | EP | disclosed |
| CN-119707776-A | Indole compound, pharmaceutical composition, preparation method and application thereof | 山东绿叶制药有限公司 | 2025-03-28 | — | — | CN | disclosed |
| US-20250084055-A1 | DIHYDROQUINOLINONES FOR MEDICAL TREATMENT | C4 THERAPEUTICS, INC. (US) | 2025-03-13 | — | — | US | disclosed |
| WO-2025014719-A2 | TROPANE COMPOUNDS FOR TREATING BRAIN DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-16 | — | — | WO | disclosed |
| CN-119144141-A | Halogen-free flame-retardant TPU cable material and preparation method thereof | 无锡市优艺新材料科技有限公司 | 2024-12-17 | — | — | CN | disclosed |
| EP-0730452-A4 | HETEROARYLPIPERIDINES, PYRROLIDINES AND PIPERAZINES AND THEIR USE AS ANTIPSYCHOTICS AND ANALGETICS | HOECHST ROUSSEL PHARMA (US) | 1997-03-19 | — | — | EP | disclosed |
| EP-0730452-A1 | HETEROARYLPIPERIDINES, PYRROLIDINES AND PIPERAZINES AND THEIR USE AS ANTIPSYCHOTICS AND ANALGETICS | HOECHST MARION ROUSSEL, Inc. (US) | 1996-09-11 | — | — | EP | disclosed |
| WO-1993020099-A2 | CCK AND/OR GASTRIN RECEPTOR LIGANDS | FERRING B.V. (NL) | 1993-10-14 | — | — | WO | disclosed |
| EP-0080419-B1 | 8-HALOALKYL-4H-(1)-BENZOPYRAN-4-ONES AND PREPARATION PROCESSES | LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) | 1990-01-24 | — | — | EP | disclosed |
| EP-0109679-B1 | PROCESS FOR THE SIMULTANEOUS PRODUCTION OF PHENYLACETATE ESTERS AND PHENYLACETALDEHYDES | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1985-08-14 | — | — | EP | disclosed |
| EP-0109679-A1 | Process for the simultaneous production of phenylacetate esters and phenylacetaldehydes | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1984-05-30 | — | — | EP | disclosed |
| EP-0080419-A2 | 8-Haloalkyl-4H-(1)-benzopyran-4-ones and preparation processes | LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) | 1983-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004798-A1 | Platinum complexes with mononitrile-containing ligands | LIG4, RNMT, LIG1 | ALDH1A1 658/4885CHRM2 3745/4885CHRM1 2340/4885 |
| US-20250084055-A1 | DIHYDROQUINOLINONES FOR MEDICAL TREATMENT | CRBN, RBX1, ADRM1 | ALDH1A1 2816/4885CHRM2 4337/4885CHRM1 4336/4885 |
| US-20070173485-A1 | Amminecyclohexanecarbonitriledichloroplatinum; platinum is capable of rapidly undergoing chelation with the Guanine or Adenine base of a DNA oligonucleotide at the 7 position; readily taken up by tumor cells | RNMT, NSUN2, NUDT1 | ALDH1A1 952/4885CHRM2 2623/4885CHRM1 1382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.